Jennifer Bath
Chief Executive Officer chez IMMUNOPRECISE ANTIBODIES LTD.
Fortune : 378 203 $ au 31/03/2024
Profil
Jennifer L.
Bath is the founder of Concordia College Global Vaccine Institute, which was founded in 2009.
She served as the Executive Director from 2009 to 2015.
Dr. Bath is currently the President, Chief Executive Officer & Director at ImmunoPrecise Antibodies Ltd.
since 2018.
Previously, she worked as the Global Director-Client Relations at Aldevron LLC from 2015 to 2018 and as an Associate Professor at Concordia University from 2005 to 2015.
Dr. Bath holds a doctorate degree from North Dakota State University and an undergraduate degree from the University of Kansas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2024 | 248 818 ( 0,95% ) | 378 203 $ | 31/03/2024 |
Postes actifs de Jennifer Bath
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Chief Executive Officer | 21/02/2018 |
Anciens postes connus de Jennifer Bath
| Sociétés | Poste | Fin |
|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Corporate Officer/Principal | 01/02/2018 |
| Concordia University | Corporate Officer/Principal | 01/08/2015 |
| Concordia College Global Vaccine Institute | Founder | 01/08/2015 |
Formation de Jennifer Bath
| North Dakota State University | Doctorate Degree |
| University of Kansas | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Health Technology |
